MARKET

BLCO

BLCO

Bausch + Lomb Corporation
NYSE
16.04
-0.23
-1.41%
Opening 14:04 05/15 EDT
OPEN
16.11
PREV CLOSE
16.27
HIGH
16.20
LOW
15.99
VOLUME
194.15K
TURNOVER
--
52 WEEK HIGH
18.92
52 WEEK LOW
10.99
MARKET CAP
5.72B
P/E (TTM)
-25.9547
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BLCO last week (0504-0508)?
Weekly Report · 4d ago
A Look At Bausch + Lomb (BLCO) Valuation After Bi Blade Plus Launch In European Surgical Market
Simply Wall St · 4d ago
Jazz, AstraZeneca, Astellas: Foreign Healthcare's strongest Quant picks
Seeking Alpha · 05/07 11:50
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe
Barchart · 05/07 06:00
Bausch + Lomb Announces Second R&D “Teach-in” Webinar
Barchart · 05/06 06:15
Will Stronger 2026 Guidance And ARVO Data Shift Bausch + Lomb's (BLCO) Innovation-Led Growth Narrative?
Simply Wall St · 05/06 03:26
Most and least shorted mid-to mega-cap healthcare stocks in May
Seeking Alpha · 05/04 13:35
H.C. Wainwright Remains a Buy on Bausch + Lomb Corporation (BLCO)
TipRanks · 05/04 10:36
More
About BLCO
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Webull offers Bausch + Lomb Corp stock information, including NYSE: BLCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLCO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLCO stock methods without spending real money on the virtual paper trading platform.